Henrik Edgren
Affiliations: | Biomedicum Biochip Center | University of Helsinki, Helsingfors, Finland |
Google:
"Henrik Edgren"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Drilon A, Somwar R, Mangatt BP, et al. (2018) Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers. Cancer Discovery |
| Kivioja JL, Lopez Martí JM, Kumar A, et al. (2017) Chimeric NUP98-NSD1 transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia. Leukemia & Lymphoma. 1-8 |
| Jernström S, Hongisto V, Leivonen SK, et al. (2017) Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response. Breast Cancer (Dove Medical Press). 9: 185-198 |
| Eldfors S, Kuusanmäki H, Kontro M, et al. (2016) Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia. Leukemia |
| Kangaspeska S, Hultsch S, Jaiswal A, et al. (2016) Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer. Bmc Cancer. 16: 378-378 |
| Tumiati M, Munne PM, Edgren H, et al. (2016) Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers. Oncogene |
| Edgren H, Ruusulehto A, Ojala K, et al. (2016) Abstract 4505: Pan-cancer analysis of fusion gene druggability and neoantigen potential Cancer Research. 76: 4505-4505 |
| Ojamies PN, Kontro M, Edgren H, et al. (2016) Abstract 2378: Responses of AML patients to tailored drug regimens: monitoring cancer subclones by ultra-deep resequencing Cancer Research. 76: 2378-2378 |
| Werner S, Brors B, Eick J, et al. (2015) Suppression of early hematogenous dissemination of human breast cancer cells to bone marrow by retinoic Acid-induced 2. Cancer Discovery. 5: 506-19 |
| Edgren H, Ojala K, Ruusulehto A, et al. (2015) Abstract 4793: Rapid pan-cancer identification of previously unidentified fusion genes to enable novel targeted therapeutics Cancer Research. 75: 4793-4793 |